A
Amel A. Refaie
Publications - 11
Citations - 232
Amel A. Refaie is an academic researcher. The author has contributed to research in topics: Oxidative stress & Prallethrin. The author has an hindex of 7, co-authored 10 publications receiving 187 citations.
Papers
More filters
Journal ArticleDOI
Amelioration of prallethrin-induced oxidative stress and hepatotoxicity in rat by the administration of Origanum majorana essential oil.
TL;DR: Prallethrin caused oxidative damage and liver injury in male rat and co-administration of EO attenuated the toxic effect of prallethrin, demonstrating that administration of Eo may be useful, easy, and economical to protect human against pyrethroids toxic effects.
Journal ArticleDOI
Effect of Exposure to Mixture of Four Organophosphate Insecticides at No Observed Adverse Effect Level Dose on Rat Liver: The Protective Role of Vitamin C
Journal ArticleDOI
Hepatoprotective Efficacy of Cichorium intybus L. Extract Against Carbon Tetrachloride-induced Liver Damage in Rats
TL;DR: It is ascertain that the herb extracts of C. intybus possess significant hepatoprotective activity against carbon tetrachloride intoxicated male albino rats.
Journal ArticleDOI
Oxidative damage and nephrotoxicity induced by prallethrin in rat and the protective effect of Origanum majorana essential oil.
TL;DR: Prallethrin induced oxidative damage and renal toxicity in male rat and the administration of essential oil provided significant protection against prallethrin-induced oxidative stress, biochemical changes and histopathological damage.
Journal ArticleDOI
Antimutagenic Effect of Origanum majorana L. Essential Oil Against Prallethrin-Induced Genotoxic Damage in Rat Bone Marrow Cells
TL;DR: It is demonstrated that prallethrin at dose 64.0 mg/kg body weight (b.wt.) has a clastogenic/genotoxic potential as shown by the high percentage of chromosomal aberration and micronucleus in the bone marrow cells of male rats, whereas the combined treatment of prallehrin and O. majorana EO resulted in the reduction of the CA.